APP and early-onset autosomal dominant Alzheimer disease: Many studies have demonstrated that transgenic mice with expression of human APP carrying Alzheimer disease–causing mutations in the brain have high levels of toxic Aβ, neuronal pathophysiology, memory impairments, and plaque formation [1].